Spectrum of Parkinson's disease, Parkinson's dementia, and Lewy body dementia. (Q34079598)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072265%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

review article

1 reference

title

Spectrum of Parkinson's disease, Parkinson's dementia, and Lewy body dementia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072265%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072265%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

0 references

McKeith IG

1

1 reference

30 July 2017

publication date

1 November 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072265%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072265%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072265%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072265%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

865-902

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072265%20AND%20SRC:MED&resulttype=core&format=json

Donepezil for dementia with Lewy bodies: a case study

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

Neuropsychiatric aspects of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

Apolipoprotein E gene in Parkinson's disease with or without dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

Idiopathic clouding of consciousness?do the patients have cortical lewy body disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

One year follow-up of parkinsonism in dementia with Lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

A prospective study of dementia with Lewy bodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

Medial temporal lobe atrophy on MRI in dementia with Lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

EEG findings in dementia with Lewy bodies and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

Immunoreactivity profile of hippocampal CA2/3 neurites in diffuse Lewy body disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

Motor and cognitive function in Lewy body dementia: comparison with Alzheimer's and Parkinson's diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

Intravenous levodopa in hallucinating Parkinson's disease patients: high-dose challenge does not precipitate hallucinations

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

Clinical and quantitative pathologic correlates of dementia with Lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

Plaque-only Alzheimer disease is usually the lewy body variant, and vice versa.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

Cholinesterase inhibition in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

Lewy body-type degeneration in cardiac plexus in Parkinson's and incidental Lewy body diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

Structural basis of dementia in neurodegenerative disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

Dementia with Lewy bodies: response of delirium-like features to donepezil.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

Recent advances in dementia research in Japan: non-Alzheimer-type degenerative dementias

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

Accuracy of the Clinical Diagnoses of Lewy Body Disease, Parkinson Disease, and Dementia With Lewy Bodies

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

Comparison of extrapyramidal features in 31 pathologically confirmed cases of diffuse Lewy body disease and 34 pathologically confirmed cases of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

Sensitivity and specificity of three clinical criteria for dementia with Lewy bodies in an autopsy-verified sample

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

Neuroleptic sensitivity in patients with senile dementia of Lewy body type

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

Neuroleptic sensitivity to risperidone in Lewy body dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

Rivastigmine in the treatment of dementia with Lewy bodies: preliminary findings from an open trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

Apolipoprotein E genotyping in Alzheimer's disease. The UK Alzheimer's Disease Genetic consortium

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

Diagnosing dementia with Lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

Report of the second dementia with Lewy body international workshop: diagnosis and treatment. Consortium on Dementia with Lewy Bodies

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

Operational criteria for senile dementia of Lewy body type (SDLT)

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

Prospective study of relations between cortical Lewy bodies, poor eyesight, and hallucinations in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

Dementia with Lewy bodies: reliability and validity of clinical and pathologic criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

Extrapyramidalism in Alzheimer's disease: prevalence, psychiatric, and neuropsychological correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

Molecular biology of APO E alleles in Alzheimer's and non-Alzheimer's dementias.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

Psychotic symptoms in Parkinson's disease patients with dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

Cholinergic transmitter and neurotrophic activities in Lewy body dementia: similarity to Parkinson's and distinction from Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

Evidence of a Monoaminergic-Cholinergic Imbalance Related to Visual Hallucinations in Lewy Body Dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

Neocortical lewy body counts correlate with dementia in the Lewy body variant of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

Donepezil for treatment of dementia with Lewy bodies: a case series of nine patients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

Quantifying fluctuation in dementia with Lewy bodies, Alzheimer's disease, and vascular dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

Neuropsychological performance in Lewy body dementia and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

In-vivo demonstration of dopaminergic degeneration in dementia with Lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

Concentric hyaline inclusion body formation in mental disease analysis of twenty-seven cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

Ondansetron for hallucinosis in advanced Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970230-9

7 January 2021

10.1016/S0733-8619(05)70230-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072265%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference